Family: | Blackrock (iShares) |
Name: | iShares Biotechnology ETF |
Inception Date: | 5-Feb-2001 |
Termination Date: | |
Investment Objective: | The iShares Biotechnology ETF seeks to track the investment results of an index composed of U.S.-listed equities in the biotechnology sector. It provides exposure to U.S. companies in the biotechnology industry. |
Prospectus | |
Top 10 Holdings | ||
AMGEN INC | AMGN | 8.6501% |
VERTEX PHARMACEUTICALS INC | VRTX | 8.3334% |
REGENERON PHARMACEUTICALS INC | REGN | 8.1325% |
GILEAD SCIENCES INC | GILD | 8.0503% |
IQVIA HOLDINGS INC | IQV | 4.5162% |
MODERNA INC | MRNA | 3.8138% |
BIOGEN INC | BIIB | 2.9361% |
METTLER TOLEDO INC | MTD | 2.7667% |
ILLUMINA INC | ILMN | 2.0753% |
ARGENX SE ADR | ARGX | 1.9832% |
Top 10 Holdings Weight: | 51.3% |
Number of Holdings: | 225 |
Shares Outstanding: | 55,550,000 |
Total Net Assets: | 7,111,511,000 |
NAV: | 128.06 |
Net Expense Ratio: | 0.45% |
Asset Class: | Equities (Stocks) |
Developed or Emerging: | Developed Market Funds |
Country: | US |
Region: | |
Strategy: | |
Currency: | |
Commodity: | |
Sector: | Healthcare |
Industry: | Biotech |
Dividend Type: | |
Tax Exempt State: | |
Maturity Duration: | |
Market Cap: | Large & Mid Cap |
Credit Quality: | |
Mortgage Bond Types: | |
Bond Type: | |
Gov't Bond Types: | |
Reit Type: | |
Leverage Direction/Factor: | |
Is Currency Hedged: | No |
US or Ex-US: | Domestic |